NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$5.25
−6.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.81x
- PEG TTM
- 1.07x
- Price / book
- 7.64x
- Price / sales
- 26.65x
- Price / cash flow
- -34.19x
Enterprise value
- Enterprise value
- $218.5M
- EV / sales
- 25.27x
- EV / EBITDA
- 37.89x
- EV / EBIT
- 37.89x
- Market cap
- $230.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025